Ramachandran R - Search Results

1

US Food and Drug Administration Review Time of Supplemental New Indication Approvals of Drugs and Biologics, 2017 to 2019.

Dhodapkar MM, Ross JS, Ramachandran R. Dhodapkar MM, et al. Among authors: ramachandran r. JAMA Netw Open. 2023 Jun 1;6(6):e2318889. doi: 10.1001/jamanetworkopen.2023.18889. JAMA Netw Open. 2023. PMID: 37358857 Free PMC article.

2

The updated AMSA scorecard of conflict-of-interest policies: a survey of U.S. medical schools.

Carlat DJ, Fagrelius T, Ramachandran R, Ross JS, Bergh S. Carlat DJ, et al. Among authors: ramachandran r. BMC Med Educ. 2016 Aug 12;16(1):202. doi: 10.1186/s12909-016-0725-y. BMC Med Educ. 2016. PMID: 27519253 Free PMC article.

3

Future of covid-19 vaccine pricing: lessons from influenza.

Ramachandran R, Dhodapkar M, Ross JS, Schwartz JL. Ramachandran R, et al. BMJ. 2021 Jun 22;373:n1467. doi: 10.1136/bmj.n1467. BMJ. 2021. PMID: 34158283 No abstract available.

4

Early experience with the FDA's regulatory review of novel gene therapies.

Puthumana J, Egilman AC, Ramachandran R, Naushad N, Shah N, Ross J. Puthumana J, et al. Among authors: ramachandran r. BMJ Evid Based Med. 2022 Aug;27(4):195-198. doi: 10.1136/bmjebm-2021-111720. Epub 2021 Oct 11. BMJ Evid Based Med. 2022. PMID: 34635478 No abstract available.

5

Comparison of Duration of Postapproval vs Pivotal Trials for Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval, 2009-2018.

Wallach JD, Ramachandran R, Bruckner T, Ross JS. Wallach JD, et al. Among authors: ramachandran r. JAMA Netw Open. 2021 Nov 1;4(11):e2133601. doi: 10.1001/jamanetworkopen.2021.33601. JAMA Netw Open. 2021. PMID: 34751764 Free PMC article.

6

Strengthening the FDA's Enforcement of ClinicalTrials.gov Reporting Requirements.

Ramachandran R, Morten CJ, Ross JS. Ramachandran R, et al. JAMA. 2021 Dec 7;326(21):2131-2132. doi: 10.1001/jama.2021.19773. JAMA. 2021. PMID: 34766971 No abstract available.

7

Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials.

Ramachandran R, Ross JS, Miller JE. Ramachandran R, et al. JAMA Netw Open. 2021 Nov 1;4(11):e2134233. doi: 10.1001/jamanetworkopen.2021.34233. JAMA Netw Open. 2021. PMID: 34792596 Free PMC article.

8

Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.

Zhou T, Liu P, Dhruva SS, Shah ND, Ramachandran R, Berg KM, Ross JS. Zhou T, et al. Among authors: ramachandran r. JAMA Intern Med. 2022 Feb 1;182(2):185-195. doi: 10.1001/jamainternmed.2021.7457. JAMA Intern Med. 2022. PMID: 34982097 Free PMC article.

9

FDA Indication Extrapolations-Allowing Flexibility While Providing Greater Clarity.

Ramachandran R, Ross JS. Ramachandran R, et al. JAMA Netw Open. 2022 Apr 1;5(4):e227961. doi: 10.1001/jamanetworkopen.2022.7961. JAMA Netw Open. 2022. PMID: 35438761 Free article. No abstract available.

10

Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017.

Skydel JJ, Egilman AC, Wallach JD, Ramachandran R, Gupta R, Ross JS. Skydel JJ, et al. Among authors: ramachandran r. JAMA Health Forum. 2022 May 27;3(5):e221158. doi: 10.1001/jamahealthforum.2022.1158. eCollection 2022 May. JAMA Health Forum. 2022. PMID: 35977252 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,396 results

Search Page

Filters